ADAM8 promotes tumorigenesis, angiogenesis, and spreading of circulating tumor cells in breast cancer

被引：0

作者：

Romagnoll, Mathilde ^{[1
]}

Mineva, Nora D. ^{[1
]}

Loussouarn, Delphine ^{[2
]}

Barille-Nion, Sophie ^{[3
]}

Polmear, Mike ^{[4
]}

Georgakoudi, Irene ^{[4
]}

Conrad, Catharina ^{[5
]}

Schlomann, Uwe ^{[5
]}

Bartsch, Joerg W. ^{[5
]}

Parsons, Maddy ^{[6
]}

Sonenshein, Gall E. ^{[1
]}

机构：

[1] Tufts Univ, Sch Med, Boston, MA 02111 USA

[2] Hop G&R Laennec, Nantes, France

[3] Ctr Rec Cancerol, UMR 892, Nantes, France

[4] Tufts Univ, Boston, MA 02111 USA

[5] Univ Marburg, Marburg, Germany

[6] Kings Coll London, London WC2R 2LS, England

来源：

CANCER RESEARCH | 2013年 / 73卷

关键词：

D O I：

10.1158/1538-7445.TIM2013-B62

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

B62

引用

页数：2

共 50 条

[1] ADAM8 expression in invasive breast cancer promotes tumor dissemination and metastasis
Romagnoli, Mathilde
Mineva, Nora D.
Polmear, Michael
Conrad, Catharina
Srinivasan, Srimathi
Loussouarn, Delphine
Barille-Nion, Sophie
Georgakoudi, Irene
Dagg, Aine
McDermott, Enda W.
Duffy, Michael J.
McGowan, Patricia M.
Schlomann, Uwe
Parsons, Maddy
Bartsch, Joerg W.
Sonenshein, Gail E.
EMBO MOLECULAR MEDICINE, 2014, 6 (02) : 278 - 294
[2] Targeting ADAM8 dependent maintenance of the myCAF phenotype in the breast cancer tumor microenvironment
Mi, Zhiyong
Kuo, Paul C.
CANCER RESEARCH, 2023, 83 (05)
[3] ADAM8 deficiency in macrophages promotes angiogenesis to antagonize post-myocardial infarction cardiac injury
Ji, Z.
Guo, J.
Zuo, W.
Zhang, R.
Qu, Y.
Tao, Z.
Xu, Y.
Yao, Y.
Ma, G.
EUROPEAN HEART JOURNAL, 2023, 44
[4] Antibody targeting of ADAM8 for treatment of triple-negative breast cancer
Das, Sonia G.
Pianetti, Stefania
Sonenshein, Gail E.
Mineva, Nora D.
CANCER RESEARCH, 2017, 77
[5] ADAM8 as a drug target in pancreatic cancer
Uwe Schlomann
Garrit Koller
Catharina Conrad
Taheera Ferdous
Panagiota Golfi
Adolfo Molejon Garcia
Sabrina Höfling
Maddy Parsons
Patricia Costa
Robin Soper
Maud Bossard
Thorsten Hagemann
Rozita Roshani
Norbert Sewald
Randal R. Ketchem
Marcia L. Moss
Fred H. Rasmussen
Miles A. Miller
Douglas A. Lauffenburger
David A. Tuveson
Christopher Nimsky
Jörg W. Bartsch
Nature Communications, 6
[6] ADAM8 as a drug target in pancreatic cancer
Schlomann, Uwe
Koller, Garrit
Conrad, Catharina
Ferdous, Taheera
Golfi, Panagiota
Garcia, Adolfo Molejon
Hofling, Sabrina
Parsons, Maddy
Costa, Patricia
Soper, Robin
Bossard, Maud
Hagemann, Thorsten
Roshani, Rozita
Sewald, Norbert
Ketchem, Randal R.
Moss, Marcia L.
Rasmussen, Fred H.
Miller, Miles A.
Lauffenburger, Douglas A.
Tuveson, David A.
Nimsky, Christopher
Bartsch, Jorg W.
NATURE COMMUNICATIONS, 2015, 6
[7] ADAM8 provides new hope in pancreatic cancer
Alessia Errico
Nature Reviews Clinical Oncology, 2015, 12 (3) : 126 - 126
[8] Cohort Analysis of ADAM8 Expression in the PDAC Tumor Stroma
Jaworek, Christian
Verel-Yilmaz, Yesim
Driesch, Sarah
Ostgathe, Sarah
Cook, Lena
Wagner, Steffen
Bartsch, Detlef K.
Slater, Emily P.
Bartsch, Joerg W.
JOURNAL OF PERSONALIZED MEDICINE, 2021, 11 (02): : 1 - 10
[9] ADAM8 affects glioblastoma progression by regulating osteopontin-mediated angiogenesis
Li, Yu
Guo, Songbo
Zhao, Kai
Conrad, Catharina
Driescher, Caroline
Rothbart, Vanessa
Schlomann, Uwe
Guerreiro, Helena
Bopp, Miriam H.
Koenig, Alexander
Carl, Barbara
Pagenstecher, Axel
Nimsky, Christopher
Bartsch, Jorg W.
BIOLOGICAL CHEMISTRY, 2021, 402 (02) : 195 - 206
[10] ADAM8 in invasive cancers: links to tumor progression, metastasis, and chemoresistance
Conrad, Catharina
Benzel, Julia
Dorzweiler, Kristina
Cook, Lena
Schlomann, Uwe
Zarbock, Alexander
Slater, Emily P.
Nimsky, Christopher
Bartsch, Joerg W.
CLINICAL SCIENCE, 2019, 133 (01) : 83 - 99

← 1 2 3 4 5 →